Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kenneth Aldape

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Journal of Neuro-Oncology

English

Related publications

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients With Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma.

Journal of Clinical Oncology

English

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

English

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

English

Evaluation of Patient Education System to Improve Their Understanding in Patients Treated With Erlotinib or Gefitinib

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

2015

English

Phase I Trial of Sorafenib in Combination With Gefitinib in Patients With Refractory or Recurrent Non Small Cell Lung Cancer

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

British Journal of Cancer

Cancer Research

Oncology

2009

English

A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Clinical Cancer Research

Cancer Research

Oncology

2008

English

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kenneth Aldape

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Related publications

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients With Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma.

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Evaluation of Patient Education System to Improve Their Understanding in Patients Treated With Erlotinib or Gefitinib

Phase I Trial of Sorafenib in Combination With Gefitinib in Patients With Refractory or Recurrent Non Small Cell Lung Cancer

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study